SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Prevalence and risk factors for milk allergy overdiagnosis in the BEEP trial cohort.

Allen, HI; Wing, O; Milkova, D; Jackson, E; Li, K; Bradshaw, LE; Wyatt, L; Haines, R; Santer, M; Murphy, AW; et al. Allen, HI; Wing, O; Milkova, D; Jackson, E; Li, K; Bradshaw, LE; Wyatt, L; Haines, R; Santer, M; Murphy, AW; Brown, SJ; Kelleher, M; Perkin, MR; Jay, N; Smith, TDH; Moriarty, F; Montgomery, AA; Williams, HC; Boyle, RJ (2024) Prevalence and risk factors for milk allergy overdiagnosis in the BEEP trial cohort. Allergy. ISSN 1398-9995 https://doi.org/10.1111/all.16203
SGUL Authors: Perkin, Michael Richard

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Appendix S1) Supplemental Material
Download (863kB)

Abstract

BACKGROUND: Cow's milk allergy (CMA) overdiagnosis in young children appears to be increasing and has not been well characterised. We used a clinical trial population to characterise CMA overdiagnosis and identify individual-level and primary care practice-level risk factors. METHODS: We analysed data from 1394 children born in England in 2014-2016 (BEEP trial, ISRCTN21528841). Participants underwent formal CMA diagnosis at ≤2 years. CMA overdiagnosis was defined in three separate ways: parent-reported milk reaction; primary care record of milk hypersensitivity symptoms; and primary care record of low-allergy formula prescription. RESULTS: CMA was formally diagnosed in 19 (1.4%) participants. CMA overdiagnosis was common: 16.1% had parent-reported cow's milk hypersensitivity, 11.3% primary care recorded milk hypersensitivity and 8.7% had low-allergy formula prescription. Symptoms attributed to cow's milk hypersensitivity in participants without CMA were commonly gastrointestinal and reported from a median age of 49 days. Low-allergy formula prescriptions in participants without CMA lasted a median of 10 months (interquartile range 1, 16); the estimated volume consumed was a median of 272 litres (26, 448). Risk factors for CMA overdiagnosis were high practice-based low-allergy formula prescribing in the previous year and maternal report of antibiotic prescription during pregnancy. Exclusive formula feeding from birth was associated with increased low-allergy formula prescription. There was no evidence that practice prescribing of paediatric adrenaline auto-injectors or anti-reflux medications, or maternal features such as anxiety, age, parity and socioeconomic status were associated with CMA overdiagnosis. CONCLUSION: CMA overdiagnosis is common in early infancy. Risk factors include high primary care practice-based low-allergy formula prescribing and maternal report of antibiotic prescription during pregnancy.

Item Type: Article
Additional Information: © 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: cow's milk allergy, low‐allergy formula, overdiagnosis, primary care, cow's milk allergy, low-allergy formula, overdiagnosis, primary care, 1107 Immunology, Allergy
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Academic Structure > REF 2021 user group
Journal or Publication Title: Allergy
ISSN: 1398-9995
Language: eng
Dates:
DateEvent
20 June 2024Published Online
2 June 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
CA15008Children's Hospital CharityUNSPECIFIED
UNSPECIFIEDNational Institute for Health and Care Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDGoldman Sachshttp://dx.doi.org/10.13039/100022187
UNSPECIFIEDIrish College of General Practitionershttp://dx.doi.org/10.13039/100011396
12/67/12National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
106865/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
TRF-2017-10-003National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
PubMed ID: 38899450
Web of Science ID: WOS:001251941200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116617
Publisher's version: https://doi.org/10.1111/all.16203

Actions (login required)

Edit Item Edit Item